UPDATE 1-Novavax delays U.S. trial start of COVID-19 vaccine to November

In this news, we discuss the UPDATE 1-Novavax delays U.S. trial start of COVID-19 vaccine to November.

Novavax Inc on Tuesday delayed the schedule for the start of an advanced stage U.S. trial of its investigational coronavirus vaccine by about a month.

The company said it would begin the trial by the end of November. He previously planned to start this month. Novavax said it also expected provisional data from an ongoing UK trial at an advanced stage of its coronavirus vaccine in the first quarter of next year.

The company said it had widened its goal of enrolling in the UK trial to 15,000 volunteers from 10,000. It expects this may help assess the safety and effectiveness of the drug. vaccine in a shorter time.

News Highlights:

  • Novavax said it also expected provisional data from an ongoing UK trial at an advanced stage of its coronavirus vaccine in the first quarter of next year. The company said it had widened its goal of enrolling in the UK trial to 15,000 volunteers from 10,000. It expects this may help assess the safety and effectiveness of the drug. vaccine in a shorter time.
  • UPDATE 1-Novavax delays start of US COVID-19 vaccine trial until November
      Bollyinside - Latest News and Reviews
      Enable registration in settings - general
      Compare items
      • Total (0)
      Compare
      0